However, he is hopeful that the results could “potentially explain” some of the “geographic variation” in prostate cancer diagnoses and deaths across the US.
Prostate cancer is fueling a cancer epidemic, with 10% of new diagnoses in the US occurring in men under 55, and deaths from prostate cancer are expected to jump 136% from 2022 to 2050.
Prostate cancer is the second most common form of male cancer after skin cancer.
Indicators that advanced prostate cancer has spread include bone and back pain, weight loss, testicular pain and loss of appetite.
Endocine disruptors interfere with hormone systems, causing side effects like infertility, birth defects, developmental disorders and increased cancer risk.
A startling new study has found that over a dozen chemicals found in common weed killers like Roundup may increase the risk of prostate cancer.
Researchers examined 300 pesticides and discovered that 22 were directly associated with prostate cancer development, and four were demonstrated to raise the risk of death, according to a report published in the journal Cancer.
The study follows Bayer AG’s January $2.25 billion payment order following a unanimous Pennsylvania jury’s verdict that the company’s Roundup herbicide caused cancer in a man.
Researchers evaluated data on the yearly use of pesticides from 1997 to 2001 and from 2003 to 2006 in the new study. They then contrasted those numbers with diagnoses made between 2011 and 2015 and between 2016 and 2020, respectively, taking into account the slow-growing nature of prostate cancer.
Of the 22 pesticides linked to an increased risk of prostate cancer, the team found that 19 had never been linked to the disease before.
A higher risk of dying from prostate cancer was associated with four of the 22 pesticides: trifluralin, cloransulam-methyl, thiamethoxam, and diflufenzopyr.
Dr. According to Stanford University prostate cancer specialist Simon John Christoph Soerensen, the study’s lead author, his team’s observational research cannot establish causation. He is optimistic, though, that the findings may “potentially explain” a portion of the “geographic variation” in prostate cancer deaths and diagnoses in the United States.
“We can endeavor to lower the number of men afflicted by this disease by expanding on these findings,” he stated.
Prostate cancer is contributing to the cancer epidemic; in the United States, men under the age of 55 account for 10% of new diagnoses, and the disease is predicted to cause 136% more deaths between 2022 and 2050.
After skin cancer, prostate cancer is the second most common type of cancer in men. Because prostate cancer is often low-grade, slow-growing, and has a wide range of treatment options, the American Cancer Society states that it is not usually fatal.
The National Institutes of Health estimates that only one in 39 men (or 2 percent) will die from prostate cancer, despite the fact that one in eight men will receive a diagnosis.
Like all cancers, survival depends on early detection and treatment.
Prostate cancer can be treated with radiation, immunotherapy, chemotherapy, surgery, or targeted medication therapy.
The prostate gland, which is located beneath the bladder, is primarily responsible for ejaculation and semen production.
Urinary symptoms such as a sudden urge to urinate and/or trouble starting the steam, weak flow, or straining can be signs of prostate issues.
In addition to symptoms related to the urinary system, blood in the urine or semen should be discussed with a physician right away. Loss of appetite, testicular pain, weight loss, and back and bone pain are signs that advanced prostate cancer has spread.
As agricultural support, pesticides such as those found in this most recent study are used to control insect and rodent infestations, kill weeds, and maintain crops.
Since 1990, the use of pesticides has increased by almost 60%, reaching 5.86 billion pounds by 2020, according to the Daily Mail. Chemicals used specifically to eradicate weeds, such as herbicides, are grouped together under the general term “pesticides.”.
The herbicide glyphosate, a known endocrine disruptor, is said to be present in 41% of Roundup, the most popular weed killer in the United States.
Hormone system disruption from endocine disruptors can result in infertility, birth defects, developmental disorders, and an elevated risk of cancer.
Additionally, roundup contains 2,4-dichloroacetic acid, or 2,4-D. In animals, prenatal exposure to 2,4-D has been associated with reduced body weight and behavioral problems in the fetus. Independent studies have linked 2,4-D exposure to a higher risk of lymphoma, as well as liver and kidney damage.
The makers of Roundup, Monsanto and its parent company Bayer AG, have stated time and time again that there is no risk to human health from their products.
However, a Pennsylvania jury unanimously decided earlier this year that Bayer AG’s Roundup weed killer caused a man to develop cancer, and the company was ordered to pay $2.25 billion.
The 49-year-old John McKivinson filed a lawsuit against Monsanto, the company that makes Roundup, and Bayer, its corporate parent, claiming that he had non-Hodgkin’s lymphoma after using the herbicide on his property for 20 years.
The enormous settlement includes $2 billion in punitive damages, McKivinson’s lawyers at Kline and Specter previously told The Post.
Members of the jury also concluded that Monsanto failed to adequately warn consumers about Roundup’s risks.
The jury’s verdict is “a declaration that its misconduct was a substantial cause of John McKivison’s cancer and a reckless disregard of human safety.”. “”.
